Morgan Stanley’s Loncar China BioPharma ETF CHNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $2.68K | Hold |
|
|||||
|
2023
Q2 | $3.04K | Hold |
|
|||||
|
2023
Q1 | $3.35K | Hold |
|
|||||
|
2022
Q4 | $3.53K | Hold |
|
|||||
|
2022
Q3 | $3K | Hold |
|
|||||
|
2022
Q2 | $4K | Hold |
|
|||||
|
2022
Q1 | $4K | Sell |
|
|||||
|
2021
Q4 | $59K | Hold |
|
|||||
|
2021
Q3 | $82K | Hold |
|
|||||
|
2021
Q2 | $104K | Hold |
|
|||||
|
2021
Q1 | $81K | Buy |
|
|||||
|
2020
Q4 | $65K | Hold |
|
|||||
|
2020
Q3 | $61K | Hold |
|
|||||
|
2020
Q2 | $61K | Hold |
|
|||||
|
2020
Q1 | $45K | Hold |
|
|||||
|
2019
Q4 | $50K | Hold |
|
|||||
|
2019
Q3 | $44K | Hold |
|
|||||
|
2019
Q2 | $44K | Hold |
|
|||||
|
2019
Q1 | $48K | Hold |
|
|||||
|
2018
Q4 | $38K | Buy |
|